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In gastric cells isolated by pronase digestion from the guinea pig, histamine stimulated CAMP production 
in 3 fundic cell fractions (EC50 = 1.6-2 x 10m4 M) enriched in parietal (94%), peptic (63%) and mucous 
cells (87%) as well as in antral cells (EC5o = 4 x 10e4M) that are devoid of parietal cells. Histamine 
stimulations were completely inhibited by the H2 antagonist cimetidine (Ki = 0.27-0.57 x 1O-6 M) or by 
the H1 antagonist diphenhydramine, but at lOO-times lower potency (Ki = 22-45.7 x 10m6 M), indicating 
the presence of histamine Hz receptors in parietal and nonparietal cells of the guinea pig gastric mucosa. 
Histamine Fundic, antral cell HZ receptor Cyclic AMP Gastric secretion 
1. INTRODUCTION were also analyzed as control, without further 
separation. 
In vivo, histamine regulates endocrine [l] and 
exocrine secretions of acid and pepsin [2,3] by the 
stomach. In gastric mucosa, histamine is stored in 
mast cells as well as in endocrine-like cells [4] and 
could have an endocrine-paracrine role on these 
gastric secretions. We have demonstrated that 
histamine interacts with typical H2 receptors medi- 
ating cellular CAMP production, adenylate cyclase 
[5] and CAMP-dependent protein kinase [6] activa- 
tion in gastric glands isolated from the guinea pig 
fundus or antrum. Since it is now well accepted 
that histamine stimulates gastric acid secretion 
through H, receptors linked to CAMP generation 
in parietal cells [7], we have suggested [6] that gas- 
tric cells other than parietal cells bear an hista- 
mine-sensitive CAMP system. In order to explore 
this possibility, we have studied the effect of hista- 
mine and its H, or Hz antagonists on CAMP levels 
in antral and in fundic cell fractions [8] enriched in 
parietal (94vo), peptic (63%) and mucous cells 
(87%). Gastric cells isolated by the same method 
from the antral mucosa (devoid of parietal cells) 
Here, we show that not only parietal cells, but 
also non-parietal cells isolated from the guniea pig 
gastric mucosa (peptic and mucous cells from the 
fundus) as well as antral cells bear histamine Hz 
receptors linked to the CAMP generating system. A 
preliminary description of these experiments has 
been presented in abstract form [9]. 
2. MATERIALS AND METHODS 
2.1. Materials 
Histamine dihydrochloride, diphenhydramine 
(DPH), CAMP and 3-isobutyl-1-methylxanthine 
(IBMX) were from Sigma Chemicals (St Louis 
MO); and carrier-free Na12jI, IMS 300, from the 
Radiochemical Center (Amersham). Cimetidine 
was a generous gift from Dr Brimblecombe of 
Smith, Kline and French Laboratories, Ltd 
(Welwyn Garden City, Hertfordshire). Highly 
purified natural porcine VIP (lot 79.4.25) was ob- 
tained from Professor V. Mutt (GIH Laboratory, 
Stockholm) and synthetic ovine cyclic somatosta- 
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tin-14 (lot B 00926) was purchased from Beckman 
(Switzerland). All other chemicals were of analyti- 
cal grade. 
2.2. Isolation and separation of epithelial cells 
from guinea pig stomach 
Male Hartley Dunkin guinea pigs (300-450 g), 
maintained on ad libitum diet during the week pre- 
ceding the experiments were killed by cervical dis- 
location and exsanguination. Isolated epithelial 
cells were prepared as in [8]. Cells were dispersed 
by incubation at 37”C, under gassing with 95% 
02-5% CO2 in a solution of 0.15% pronase in 
Krebs Ringer bicarbonate buffer (pH 7.5) for 60 or 
90 min to obtain the isolated fundic (fraction F) or 
antral (fraction A) cells, respectively. Fraction F 
was further separated by velocity sedimentation at 
unit gravity in a solution of Ficoll 70 (Pharmacia, 
Uppsala) in Krebs Ringer bicarbonate buffer con- 
taining 0.03% bovine serum albumin. A linear 
l-370 Ficol70 gradient was formed under the cell 
layer, and the cells were sedimented uring 1 h at 
4’C. Then, 10 ml samples were collected from the 
chamber of sedimentation and pooled in 3 frac- 
tions according to the repartition of cell diameters 
[l?]. Fraction I contained 87% mucous-secreting 
cells (11.2 f 1.6 /cm), fraction II contained 63% 
chief cells (15.8 f 2.2 pm) and fraction III con- 
tained 94% parietal cells (22.0 + 2.8 pm). The 
samples from the fundic mucosa as well as fraction 
A were centrifuged at 200 x g for 2 min and cell 
pellets were resuspended and washed twice in 
Krebs Ringer phosphate buffer (pH 7.5) to a final 
concentration of 0.3-0.5 x lo6 cells/ml (fraction 
III) or l-l.5 x lo6 cells/ml (fraction A, I and II). 
About 96% of cells excluded trypan blue and their 
ATP content, measured by bioluminescence, re- 
mained stable over a 3 h period when incubated 
under the conditions described for CAMP analysis 
(vide infra). Cell protein concentration was meas- 
ured as in [lo] using bovine serum albumin as 
standard. 
2.3. Morphological studies on guinea pig gastric 
cells 
For electron microscopy, cells were fixed and 
processed as in [8]. Semi-thin sections were cut 
from Epon blocks and stained with toluidine blue 
and examined by light microscopy. Under our ex- 
perimental conditions, no parietal cells were found 
in the preparations of isolated antral cells. 
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2.4. Cyclic AMP analysis 
The incubation of gastric cells from the guinea 
pig fundus or antrum was performed in 0.5 ml 
Krebs Ringer phosphate buffer (pH 7.5), con- 
taining 1% bovine serum albumin and 0.5 mM 
IBMX, a competitive inhibitor of the CAMP-phos- 
phodiesterase activity. In a standard assay, cell sus- 
pensions were incubated (2O”C, I h) with con- 
tinuous gentle agitation. After 10 min preincuba- 
tion, the reaction was initiated by the addition of 
100 ~1 reagents. The incubation was stopped at the 
time indicated by the addition of 50 ,J 1 I N 
NC104. Cyclic AMP production was determined 
by radioimmunoassay [l I], by the use of r2’I-tyro- 
syl-succinyl-cyclic AMP and the antibody 301-8, 
as in [ 12,131. All determinations were performed in 
duplicate or triplicate. 
2.5. Processing of the data and statistical analysis 
The data were normalized as the percentage of 
the response to a given concentration of stimulant, 
at a given incubation time. These calculations ac- 
counted for the variability of the CAMP response 
in the different cellular preparations and therefore 
permitted the comparison between individual 
experiments. Absolute values are given as pmol 
CAMP produced/IO6 cells. The apparent EC’,, and 
1C,, values were the doses required to produce, 
respectively, 50% of the maximal stimulation or 
inhibition produced by the test agents. Antagonism 
by H, and H2 antihistamines was analyzed as- 
suming competitive inhibition [ 14- 161, according 
to the equation in [17] 
Ki = ICse/( 1 + S/EC,c) 
where: 
Ki = the inhibition constant of antagonist; 
S = the histamine concentration 
Results were analyzed by standard methods using 
Student’s paired t-test. 
3. RESULTS 
3.1. Effects of time and histamine on CAMP levels 
in fundic and antral cells 
In the 4 cellular fractions incubated 1 h at 20°C 
in the presence of 0.5 mM IBMX, basal CAMP 
levels ranged from 4.45 f 1.13-6.73 f 2.3 pmol 
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Basal and histamine-stimulated CAMP levels in cell fractions separated from the guinea pig fundus or antrum 
Cell Major cell 
fractions type (%) 
CAMP (pmol/106 cells) Parietal Protein 
Basal Histamine % of maximum 
cells (To) bg/106 cells) 
III Parietal (94%) 5.5 k 0.5 457 f 51 100% 94 700*21 
II Peptic (63%) 5.2 + 0.3 124 f 21 27 f 4% 16 254 f 11 
I Mucous (87%) 4.45 f 0.4 13 f 18 16 + 3% 2.3 198 + 20 
A (antral) 6.73 + 0.8 21* 2 5* 1% 0 227 f 13 
The relative efficacies of histamine in stimulating CAMP generation in epithelial cells separated from the guinea pig fun- 
dus were compared to the percentage of parietal cells present in the cell fractions. In each of 7 preparations of cells, 
the CAMP response to 10e3 M histamine was calculated as pmol cAMP/106 cells. The percent of maximum was 
obtained in each cell fraction by ascribing the value of 100% to the CAMP production observed in parietal cells 
cAMP/106 cells and histamine (10V3 M) stimu- 
lated CAMP generation in all the isolated gastric 
cell fractions (table 1). The maximal response of 
CAMP to 10e3 M histamine occured at 30 min in 
fractions A and III, at 60 min in fractions I and II, 
and plateaued up to 90 min in the 4 cell fractions 
(fig. 1). No change in basal CAMP levels was ob- 
served in the 4 cell fractions, according to the time 
of incubation. Histamine (10m3 M) produced 3-, 
16-, 24- and 83-fold stimulation in CAMP ac- 
cumulation in cell fractions A, I, II and III, respec- 
tively (table 1). Under basal conditions and after 
the addition of 10e3 M histamine, we have verified 
that CAMP levels in those 4 fractions were linearly 
correlated with the number of cells in a wide range 
from 0.5-4 x lo6 cells/ml (fractions A, I, II) and 
from 0.17-0.7 x lo6 cells/ml (fraction III). In 
view of the remarkable efficacy of histamine in 
stimulating CAMP production in the parietal cell 
fraction, it was conceivable that the histamine ef- 
fect observed in cell fractions I, II and A might be 
due to a ‘contamination’ by parietal cells. The 
relative efficacies of histamine on CAMP produc- 
tion in these different cell fractions are therefore 
presented in table 1 to explore this possibility. For 
each individual preparation, maximal CAMP 
generation induced by 10m3 M histamine in the 
parietal cell fraction was assigned to a value of 
100% and the relative efficacies for histamine in 
other cell populations was then calculated. The 
protein content in the cell fractions, which is a 
function of the cell diameter and function of the 
parietal cell concentration [8] is also presented in 
100 
0 
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0 
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Fig. 1 Time course of histamine-induced CAMP ac- 
cumulation in cell fractions isolated from the guinea pig 
fundus or antrum. Cells were suspended in standard 
solution containing 0.5 mM IBMX and were incubated 
at 20°C in the absence (control, q ) or in the presence of 
10m3 M histamine (0). Data are the mean of 2-3 expt 
performed in duplicate or triplicate. 
table 1. These values agreed with those in [8]. Our 
results clearly indicate that the relative efficacies of 
histamine on CAMP in fractions I, II, III and A did 
not correlate linearly with the percentage of pari- 
eta1 cells present in the cell preparation, suggesting 
the presence of histamine receptors mediating 
CAMP synthesis in non-parietal cells. Indeed, 16% 
of parietal cells in fraction II (enriched in chief 
87 
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Fig. 2. Stimulation by various concentrations of histamine and inhibition by cimetidine or diphenhydramine of CAMP 
levels in cell fractions separated from the guinea pig fundus or antrum. Results were normalized to the 100% maximal 
response to lo-* M histamine (0). Cimetidine (A) or diphenhydramine (0) at 10m4 M were tested in combination with 
10e3 M histamine. Each point is the mean f SEM of the results of 4-5 expt performed in duplicate or triplicate. 
cells) and only 2% of parietal cells in fraction I 
(enriched in mucous-secreting cells) were able to 
produce respectively 27% and 16% of the amount 
of CAMP synthetized by fraction III which con- 
tained -94% of parietal cells. 
3.2. Chemical characterization of the histamine- 
induced CAMP accumulation in cell fractions 
isolated and separated from the fundus or 
antrum 
The stimulatory effect of histamine was dose- 
dependent over 10-6-10-2 M (fig. 2). Half-maxi- 
mal increase of CAMP caused by histamine was 
observed at 1.6 x 10m4 M (fraction III), at 2 x lop4 
M (fraction I and II) and at 4 x 10e4 M (fraction 
A). This figure also indicates that addition of the 
H2 receptor antagonist cimetidine at 10d4 M in 
combination with 10e3 M histamine in the 4 frac- 
tions resulted in a 100% inhibition of the increase 
caused by histamine. When the same experiment 
was conducted in the presence of the Hi receptor 
blocker diphenhydramine at low4 M, CAMP levels 
were only reduced by 23, 35, 51 and 62% in frac- 
tions III, II, I and A, respectively. Here, we assign- 
ed the value of 100% to the CAMP rise observed in 
the presence of 10e3 M histamine. Cyclic AMP 
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production stimulated by 10m3 M histamine in 
fractions I, II and III was gradually and completely 
inhibited by increased concentrations of the Hi 
receptor antagonist DPH (10-5-10-2 M) or by the 
H2 receptor antagonist cimetidine and 22, 26.6 
and 45.7 x 10m6 M diphenhydramine in parietal, 
peptic and mucous cell fractions, respectively. 
4. DISCUSSION 
These data indicate that histamine can directly 
stimulate CAMP production, through H, recep- 
tors, in non-parietal cells isolated from the guinea 
pig fundus or antrum. 
In gastric cells separated from the fundus, it was 
shown that the efficacy of histamine on parietal 
cells is 3.7- and 6.3-times higher than that of the 
peptic or mucous cell fractions, respectively. Ac- 
cordingly, the efficacy of histamine on CAMP pro- 
duction, adenylate cyclase [5] or CAMP-dependent 
protein kinase [6] activations was 2-4-times higher 
in fundic than in antral glands (where parietal cells 
are absent). In contrast, histamine had no effect on 
enterocytes isolated from the guinea pig duodenum 
[5], indicating the cellular specificity of the CAMP 
stimulations by histamine in the 4 gastric cell frac- 
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Fig. 3. Dose-response curves for the inhibition by 
cimetidine or by diphenhydramine of CAMP production 
induced by 10m3 M histamine (0) in cell fractions 
separated from the guinea pig fundus. Histamine and 
cimetidine (A) or diphenhydramine (0) were added to 
the cells simultaneously and the incubation continued 
for 60 min at 20°C in the presence of 0.5 mM IBMX. 
Data are mean f half-range of two separate xperiments 
performed in duplicate. For these two preparations, 
protein concentrations were: 666-675, 270-225 and 
184-168 pg/106 parietal, peptic and mucous cells, 
respectively. 
tions studied. However, we cannot exclude the 
presence of undifferentiated parietal cells sedimen- 
ting with the fundic cell fractions enriched in peptic 
cells or mucous cells during the density gradient 
separation. Indeed, surface receptors for histamine 
could be considered in stem cells before morpho- 
logical or functional differentiation of the gastric 
cells, since this amine can increase CAMP produc- 
tion in gastric glands isolated from the human [18] 
or rat [19] fetuses. 
The pharmacological specificity of the histamine 
receptors evidenced here was determined by the use 
of the selective H2 antagonist cimetidine and H1 
antagonist diphenhydramine. The measured KS0 
and calculated Ki values for these two antihista- 
mines indicate that diphenhydramine was -lOO- 
times less potent than cimetidine on CAMP produc- 
tion induced by histamine (fig. 3). The inhibition 
constants obtained for cimetidine and diphen- 
hydramine in these 3 cellular fractions isolated 
from the fundus are in agreement with the values 
of Ki determined for the histamine H2 receptor 
characterized in guinea pig fundic and antral 
glands [5,20] or in gastric [21] or non-gastric cells 
[15,16] containing histamine H, receptors. Our 
results are similar to those obtained in the piglet 
gastric mucosa [22]: these investigators showed 
that surface epithelial cells isolated from the fun- 
dus contain an histamine-sensitive CAMP system 
that has IO-fold lower activity than that of the 
parietal cell-rich fraction. However, they further 
showed that the activation of adenylate cyclase by 
histamine in the surface cells could be blocked by 
the H, antagonist promethazine but not by the Hz 
blocker cimetidine. This difference could be ex- 
plained by the loss of the H2 specificity of the 
histamine receptor during cellular or adenylate 
cyclase preparations, as observed in [23]. Here we 
have observed that preparations of fundic or antral 
cells (even without subsequent separation) by the 
enzymatic digestion with pronase [8] caused a loss 
of the CAMP regulations by VIP or somatosta- 
tin-14, shown in gastric glands isolated by means 
of EDTA from the guinea pig [5,6]. The differen- 
tial effects of pronase digestion on the expression 
of cell surface receptors for VIP, somatostatin and 
histamine in the system indicate that the regulatory 
components of the receptor CAMP systems sen- 
sitive to VIP or to somatostatin-14 on one hand 
and to histamine on the other were chemically dif- 
ferent. This hypothesis can be directly tested by 
binding studies using [3H]histamine [24] or the 
*251-labelled peptides. 
The presence of recognition sites for histamine 
in non-parietal cells in this study correlates with the 
in vivo regulation by histamine of pepsin [3,25] 
and somatostatin [I] secretions by the stomach 
since in both cases, stimulation or inhibition are 
H, receptor-mediated effects. Finally, our results 
suggest hat muco-peptic and somatostatin secre- 
tions by the stomach could be regulated, via 
CAMP, after cell-surface stimulation of histamine 
H2 receptors. 
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